Experimental studies with Stronglyloides papillosus in goats.
Unusual clinical and pathological observations in the field in goats and sheep suffering from Strongyloides papillosus infection prompted experimental work on this parasite. Goats were infected percutaneously with either single or multiple, low or high levels of S. papillosus. Young goats up to 12 months of age were found to be the most susceptible. Some animals, however, showed substantial resistance to infective doses. Clinical signs included transient diarrhoea, misshapen, elongated faecal pellets terminally, dehydration, anorexia, cachexia, gnashing of teeth, foaming at the mouth, anaemia and nervous signs such as ataxia, a wide-based stance, stupor and nystagmus. A 'pushing syndrome' was seen in 22% of the animals. The pathological changes are described and included enteritis, status spongiosus in the brain, hepatosis leading to rupture of the liver, nephrosis, pulmonary oedema, interstitial pneumonia and pneumonia. About 6% of the goats died acutely from fatal hepatic rupture. The development of an acquired immunity was determined. The immunity elicited an allergic skin reaction at the application site of larvae or injection sites of larval metabolites. This immunity, however, could be breached by large doses of larvae. The most profound clinicopathological changes induced by the parasites were an anaemia (most pronounced in the young goats) and hypophosphataemia. Trace element analyses provided evidence of Cu, Mn and possibly Se deficiencies in some goats.
Pienaar
J G
JG
Regional Veterinary Laboratory, Potgietersrus, South Africa.
Basson
P A
PA
du Plessis
J L
JL
Collins
H M
HM
Naude
T W
TW
Boyazoglu
P A
PA
Boomker
J
J
Reyers
F
F
Pienaar
W L
WL
D000818:Animals; D004198:Disease Susceptibility / Q000662:veterinary*; D004890:Erythema / Q000469:parasitology / Q000662:veterinary*; D005260:Female; D015511:Goat Diseases / Q000276:immunology / Q000469:parasitology* / Q000473:pathology; D006041:Goats; D007109:Immunity; D012756:Sheep; D012757:Sheep Diseases / Q000276:immunology / Q000469:parasitology* / Q000473:pathology; D013321:Strongyloides / Q000254:growth & development / Q000472:pathogenicity*; D013322:Strongyloidiasis / Q000276:immunology / Q000469:parasitology / Q000473:pathology / Q000662:veterinary*; D014131:Trace Elements / Q000737:chemistry
D014131:Trace Elements